CU-40101 Liniment
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CU-40101 Liniment, covering 2024-09-19 to 2024-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects [Phase 1]